Hi Bpharma, You seem to have your finger on the pulse here and you've intimated that Recce's upcoming trial is an FDA trial "FDA was consulted and presented with the plan..." and "...organisation who do nearly all the top 130 odd major pharma FDA drug trials such as this one".
I know that it is optional but has Recce submitted an IND application for the upcoming trial or is it planning to do so? If so, then when? If not then why not? Cheers
RCE Price at posting:
40.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)